T-Therapeutics Ltd
Alison Lloyd has extensive work experience in financial management. Alison is currently the Head of Finance at T-Therapeutics Ltd since January 2023. Prior to this, they served as the Head of Finance at Kymab Ltd from September 2021 to December 2022. Alison also worked at Kymab Limited as the Group Financial Controller from June 2010 to August 2021. Their earlier experience includes a role as a Financial Accountant at Ionica Limited from June 1992 to October 1998.
Alison Lloyd attended the North London Collegiate School from 1969 to 1976, where they did not obtain a degree or have a specific field of study. Alison then went on to study at Durham University from 1976 to 1979, where they earned a Bachelor's Degree in Mathematics. Additionally, it is known that they have obtained the ACA certification from ICAEW, but the specific month and year of obtaining the certification are not provided.
This person is not in any teams
T-Therapeutics Ltd
T-Therapeutics is a venture-backed company on a mission to unlock the power of T cells to treat chronic and infectious diseases. Based on technology from Professor Allan Bradley’s laboratory in Cambridge University’s Department of Medicine, T-Therapeutics has secured significant investment from a blue-chip syndicate of investors to support its drug discovery efforts and prepare candidates for clinical development. T-Therapeutics was founded in 2022, and we are at the very beginning of our journey to develop transformative T cell derived medicines. To realise our ambition, we are currently building facilities, recruiting staff, and establishing our research operations.